Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. (Q48180007)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. |
scientific article |
Statements
1 reference
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. (English)
1 reference
Granger CV
1 reference
Rudick RA
1 reference
Cookfair DL
1 reference
Simonian NA
1 reference
Ransohoff RM
1 reference
Richert JR
1 reference
Jacobs LD
1 reference
Herndon RM
1 reference
Salazar AM
1 reference
Fischer JS
1 reference
Goodkin DE
1 reference
Simon JH
1 reference
Bartoszak DM
1 reference
Bourdette DN
1 reference
Braiman J
1 reference
Brownscheidle CM
1 reference
Coats ME
1 reference
Cohan SL
1 reference
Dougherty DS
1 reference
Kinkel RP
1 reference
Mass MK
1 reference
Munchsauer FE
1 reference
O'Reilly K
1 reference
Priore RL
1 reference
Whitham RH
1 reference
1 January 1999
1 reference
1 reference
93
1 reference
8-14
1 reference
1-2
1 reference
Identifiers
1 reference
1 reference